ACEMID: The purpose of this study is to conduct three-dimensional (3D) total body photography to monitor skin lesions and improve the early detection of melanoma and other skin cancersThree-dimensional total body photography for the early detection of melanoma and other skin cancers in people with low to very high risk of melanoma

Trial purpose

Diagnostic

Tumor type

Skin

Age

18+

Trial acronym

ACEMID

Summary

You may be eligible for this study if you are aged 18 or over and have a regular doctor. Note, that you do not need to have been diagnosed with skin cancer or be at risk of skin cancer to particiate in this study.

All participants will have three-dimensional (3D) total body photography (excluding skin beneath underwear and scalp) to create a record of all pigmented and non-pigmented skin lesions. 

These scans will happen at various frequencies over the 3-year study period, depending on the participant's melanoma risk group. The risk group is determined by completing a questionnaire to assess your risk of developing melanoma. As part of this study, all participants will complete yearly questionnaires about their sun behaviour, quality of life and skin cancer history.

It is hoped this research will improve identification and tracking of skin lesions (including potential melanomas) and reduce appointment times and healthcare costs. 

Conditions

This trial is treating people with a regular doctor who are willing to attend clinic visits